美国 · SEC FORM 4
CARLSMED, INC.
CARL · Nasdaq · CIK 0001794546 · Healthcare · Health Information Services
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
9 同一窗口内观察到的 Form 4 交易行
2 sales · 7 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-07-24 · B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,053,927
- 上期报告
- 1,078,500
- 日均成交量
- 73,785
- 回补天数
- 14.3
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-07-24 | Presidio Management Group XII, L.L.C.; Tansey Casey M; U.S. Venture Partners XII, L.P. | 买入 (P) | Common Stock | 200,000 | USD 15.00 | USD 3,000,000 | SEC 申报 ↗ |
| 2025-07-24 | YOUNG PHILIP M | 买入 (P) | Common Stock | 59,999 | USD 15.00 | USD 899,985 | SEC 申报 ↗ |
| 2025-07-24 | Sidow Kevin | 买入 (P) | Common Stock | 13,333 | USD 15.00 | USD 199,995 | SEC 申报 ↗ |
| 2025-07-24 | ROOT JONATHAN D | 买入 (P) | Common Stock | 466,666 | USD 15.00 | USD 6,999,990 | SEC 申报 ↗ |
| 2025-07-24 | Mittendorff Robert II | 买入 (P) | Common Stock | 1,333,333 | USD 15.00 | USD 19,999,995 | SEC 申报 ↗ |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 买入 (P) | Common Stock | 1,333,333 | USD 15.00 | USD 19,999,995 | SEC 申报 ↗ |
Form 4 申报证据
17 transaction lines in the latest 365-day window; 52 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Bertolini Jeffrey | 卖出 (S) | Common Stock | 747 | USD 14.39 | USD 10,749 | SEC 申报 ↗ |
| 2026-10-05 | Bertolini Jeffrey | 期权行权／转换 (M) | Common Stock | 747 | USD 5.92 | USD 4,419 | SEC 申报 ↗ |
| 2026-09-30 | Bertolini Jeffrey | 卖出 (S) | Common Stock | 243 | USD 13.99 | USD 3,400 | SEC 申报 ↗ |
展开近期 Form 4 证据 (16 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Bertolini Jeffrey | 卖出 (S) | Common Stock | 747 | USD 14.39 | USD 10,749 | SEC 申报 ↗ |
| 2026-10-05 | Bertolini Jeffrey | 期权行权／转换 (M) | Common Stock | 747 | USD 5.92 | USD 4,419 | SEC 申报 ↗ |
| 2026-09-30 | Bertolini Jeffrey | 卖出 (S) | Common Stock | 243 | USD 13.99 | USD 3,400 | SEC 申报 ↗ |
| 2026-09-30 | Bertolini Jeffrey | 期权行权／转换 (M) | Common Stock | 243 | USD 2.23 | USD 542 | SEC 申报 ↗ |
| 2026-09-28 | Heppenstall Richard | 奖励／授予 (A) | Common Stock | 89,286 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | YOUNG PHILIP M | 奖励／授予 (A) | Common Stock | 13,698 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | Sidow Kevin | 奖励／授予 (A) | Common Stock | 13,698 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | ROOT JONATHAN D | 奖励／授予 (A) | Common Stock | 13,698 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | OBOYLE KEVIN C | 奖励／授予 (A) | Common Stock | 13,698 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-03 | Cordonnier Michael | 期权行权／转换 (M) | Common Stock | 193,831 | USD 1.03 | USD 199,291 | SEC 申报 ↗ |
| 2026-03-02 | Cordonnier Michael | 卖出 (S) | Common Stock | 197,855 | USD 13.29 | USD 2,629,493 | SEC 申报 ↗ |
| 2026-03-02 | Cordonnier Michael | 期权行权／转换 (M) | Common Stock | 197,855 | USD 0.34 | USD 67,271 | SEC 申报 ↗ |
| 2026-01-28 | Greenstein Leonard M. | 奖励／授予 (A) | Common Stock | 44,977 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-28 | Durall William Scott | 奖励／授予 (A) | Common Stock | 44,977 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-28 | Cordonnier Michael | 奖励／授予 (A) | Common Stock | 117,316 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-28 | Casey Niall | 奖励／授予 (A) | Common Stock | 44,977 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CARL |
| CIK | 0001794546 |
| 行业 | Healthcare |
| 细分行业 | Health Information Services Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 52 transaction lines from 2025-07-22 to 2026-10-05 7 P purchase lines · 3 S sale lines · 42 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.